| P50 | author | Helmut Friess | Q15453363 |
| | Irene Esposito | Q65581417 |
| | Nathalia Giese | Q87716518 |
| P2093 | author name string | Jörg Kleeff | |
| | Wilfried Roth | |
| | Peter Schirmacher | |
| | Frank Bergmann | |
| | Ivane Abiatari | |
| | Xined Shi | |
| P2860 | cites work | Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes | Q24315805 |
| | cIAP1 Localizes to the nuclear compartment and modulates the cell cycle | Q24338725 |
| | Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759] | Q24792780 |
| | Apoptosis: targets in pancreatic cancer | Q24800170 |
| | Genetic alterations in pancreatic carcinoma | Q24801465 |
| | Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli | Q28116145 |
| | Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells | Q28202920 |
| | Anoikis mechanisms | Q28215553 |
| | Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy | Q28220281 |
| | The Survivin saga goes in vivo | Q28360685 |
| | NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation | Q29618715 |
| | XIAP is related to the chemoresistance and inhibited its expression by RNA interference sensitize pancreatic carcinoma cells to chemotherapeutics | Q33240542 |
| | The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas | Q33862984 |
| | Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions | Q34244725 |
| | Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. | Q34490284 |
| | A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer | Q34546440 |
| | Adjuvant therapy in pancreatic cancer: historical and current perspectives | Q35110205 |
| | bax, but not bcl-2, influences the prognosis of human pancreatic cancer | Q35352240 |
| | Tissue microarrays: a current medical research tool | Q35771798 |
| | Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function | Q36274969 |
| | Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control | Q36580820 |
| | Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. | Q36616034 |
| | The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma | Q38447221 |
| | Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells | Q38602933 |
| | The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases | Q40341729 |
| | Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells | Q40347589 |
| | Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. | Q40375391 |
| | Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2. | Q40533310 |
| | Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis | Q40601815 |
| | Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy | Q40622056 |
| | Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice | Q40737184 |
| | Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis | Q41460315 |
| | Cancer statistics, 2003. | Q43729872 |
| | Relationship between activation of epidermal growth factor receptor and cell dissociation in pancreatic cancer. | Q51822669 |
| | Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. | Q52590107 |
| | ras Oncogene triggers up-regulation of cIAP2 and XIAP in intestinal epithelial cells: epidermal growth factor receptor-dependent and -independent mechanisms of ras-induced transformation. | Q53355086 |
| | Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. | Q53395761 |
| | Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. | Q54022571 |
| | Enhanced expression of Silencer of death domains (SODD/BAG-4) in pancreatic cancer. | Q54052581 |
| | Bcl-2 expression in pancreas development and pancreatic cancer progression | Q58854740 |
| | Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors | Q74245159 |
| | Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer | Q77709638 |
| | Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma | Q80040456 |
| | Expression and localization of inhibitor of apoptosis proteins in normal human tissues | Q81637512 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| | apoptotic process | Q14599311 |
| | overexpression | Q61643320 |
| P304 | page(s) | 885-895 | |
| P577 | publication date | 2006-06-14 | |
| P1433 | published in | Journal of Clinical Pathology | Q6294965 |
| P1476 | title | Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer | |
| P478 | volume | 60 | |